A.R.T. Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$694,000
-72.8%
39,141
-70.0%
0.03%
-67.0%
Q1 2018$2,556,000
-36.6%
130,521
-34.4%
0.10%
-42.1%
Q4 2017$4,032,000
+97.4%
199,021
+69.2%
0.18%
+71.2%
Q3 2017$2,043,000
+1289.8%
117,621
+922.3%
0.10%
+1200.0%
Q2 2017$147,000
-84.8%
11,505
-88.3%
0.01%
-86.2%
Q4 2016$970,000
+474.0%
98,205
+601.2%
0.06%
+5.5%
Q3 2016$169,000
-33.2%
14,005
-52.3%
0.06%
+323.1%
Q2 2016$253,000
-77.8%
29,338
-75.6%
0.01%
-74.5%
Q1 2016$1,138,000
-38.6%
120,238
+12.4%
0.05%
-42.0%
Q4 2015$1,853,000
-35.2%
106,938
-49.8%
0.09%
-17.0%
Q3 2015$2,861,000
+873.1%
213,078
+1536.4%
0.11%
+960.0%
Q2 2015$294,000
-60.6%
13,021
-82.8%
0.01%
-74.4%
Q2 2014$746,000
-66.9%
75,530
-49.8%
0.04%
-67.5%
Q4 2013$2,257,000
+300.2%
150,601
+112.2%
0.12%
+566.7%
Q2 2013$564,00070,9800.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders